 Suzanne Lareau
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 30 | 2022 | 1040 | 3.920 |
Why?
| | Dyspnea | 14 | 2021 | 254 | 1.420 |
Why?
| | Fatigue | 4 | 2023 | 329 | 0.960 |
Why?
| | Medication Adherence | 3 | 2016 | 467 | 0.920 |
Why?
| | Patient Education as Topic | 7 | 2018 | 766 | 0.900 |
Why?
| | Lung Diseases | 6 | 2021 | 767 | 0.890 |
Why?
| | Exercise Therapy | 6 | 2016 | 443 | 0.820 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2021 | 96 | 0.680 |
Why?
| | Activities of Daily Living | 8 | 2019 | 413 | 0.640 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 37 | 0.630 |
Why?
| | Lung Diseases, Obstructive | 6 | 1999 | 50 | 0.620 |
Why?
| | Motor Activity | 3 | 2020 | 718 | 0.550 |
Why?
| | Disability Evaluation | 1 | 2019 | 290 | 0.530 |
Why?
| | Smoking Cessation | 2 | 2021 | 442 | 0.510 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 1081 | 0.510 |
Why?
| | Respiration | 1 | 2017 | 199 | 0.500 |
Why?
| | Patient Compliance | 2 | 2020 | 581 | 0.490 |
Why?
| | Oxygen Inhalation Therapy | 3 | 2016 | 157 | 0.490 |
Why?
| | Self Care | 3 | 2016 | 380 | 0.490 |
Why?
| | Bronchodilator Agents | 4 | 2019 | 252 | 0.490 |
Why?
| | Health Education | 1 | 2018 | 341 | 0.480 |
Why?
| | Goals | 1 | 2017 | 170 | 0.470 |
Why?
| | Patient Reported Outcome Measures | 1 | 2018 | 402 | 0.450 |
Why?
| | Respiration Disorders | 3 | 2023 | 77 | 0.450 |
Why?
| | Nebulizers and Vaporizers | 2 | 2011 | 86 | 0.450 |
Why?
| | Respiration, Artificial | 3 | 2017 | 645 | 0.440 |
Why?
| | Health Status | 3 | 2018 | 792 | 0.430 |
Why?
| | Telemedicine | 2 | 2020 | 862 | 0.420 |
Why?
| | Quality of Life | 9 | 2021 | 2892 | 0.410 |
Why?
| | Disease Progression | 4 | 2018 | 2757 | 0.370 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2526 | 0.360 |
Why?
| | Heart Failure | 3 | 2020 | 2236 | 0.360 |
Why?
| | Humans | 54 | 2023 | 137585 | 0.340 |
Why?
| | Frailty | 2 | 2023 | 170 | 0.330 |
Why?
| | Pamphlets | 2 | 2018 | 23 | 0.300 |
Why?
| | Surveys and Questionnaires | 11 | 2019 | 5778 | 0.290 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2018 | 261 | 0.280 |
Why?
| | Glucocorticoids | 1 | 2011 | 594 | 0.270 |
Why?
| | Critical Care | 1 | 2012 | 601 | 0.260 |
Why?
| | Critical Illness | 3 | 2018 | 811 | 0.240 |
Why?
| | Health Status Indicators | 3 | 2008 | 171 | 0.240 |
Why?
| | Self-Assessment | 1 | 2004 | 72 | 0.210 |
Why?
| | Metered Dose Inhalers | 2 | 2014 | 16 | 0.210 |
Why?
| | Pneumonectomy | 2 | 2021 | 152 | 0.200 |
Why?
| | Telerehabilitation | 1 | 2023 | 37 | 0.200 |
Why?
| | Respiratory Tract Diseases | 2 | 2023 | 184 | 0.190 |
Why?
| | Terminology as Topic | 1 | 2004 | 216 | 0.190 |
Why?
| | Exercise Tolerance | 4 | 2014 | 279 | 0.190 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2021 | 43 | 0.190 |
Why?
| | Walking | 1 | 2006 | 529 | 0.170 |
Why?
| | Reproducibility of Results | 6 | 2019 | 3284 | 0.170 |
Why?
| | Societies, Medical | 4 | 2018 | 820 | 0.170 |
Why?
| | Karnofsky Performance Status | 1 | 2019 | 38 | 0.150 |
Why?
| | Interdisciplinary Studies | 1 | 2018 | 27 | 0.150 |
Why?
| | Respiratory Therapy | 1 | 2018 | 23 | 0.150 |
Why?
| | Education | 1 | 2018 | 108 | 0.140 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1587 | 0.140 |
Why?
| | Medical History Taking | 1 | 1998 | 117 | 0.140 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1389 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 2 | 2019 | 565 | 0.140 |
Why?
| | Psychometrics | 2 | 2019 | 720 | 0.140 |
Why?
| | Equipment and Supplies | 1 | 2017 | 42 | 0.140 |
Why?
| | Spirometry | 1 | 1998 | 281 | 0.130 |
Why?
| | Muscarinic Antagonists | 1 | 2017 | 29 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 447 | 0.130 |
Why?
| | Administration, Inhalation | 3 | 2017 | 688 | 0.130 |
Why?
| | Smoking | 2 | 2021 | 1627 | 0.130 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2017 | 83 | 0.130 |
Why?
| | Lung | 5 | 2019 | 4060 | 0.130 |
Why?
| | Severity of Illness Index | 4 | 2018 | 2828 | 0.120 |
Why?
| | Tonsillectomy | 1 | 2017 | 89 | 0.120 |
Why?
| | Comorbidity | 2 | 2022 | 1622 | 0.120 |
Why?
| | Palliative Care | 2 | 2023 | 758 | 0.120 |
Why?
| | Education, Medical | 1 | 2018 | 266 | 0.110 |
Why?
| | Advisory Committees | 1 | 2016 | 219 | 0.110 |
Why?
| | United States | 10 | 2023 | 14841 | 0.110 |
Why?
| | Risk Factors | 3 | 2021 | 10388 | 0.110 |
Why?
| | Patient Safety | 1 | 2017 | 314 | 0.100 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 740 | 0.100 |
Why?
| | Aged | 10 | 2023 | 23961 | 0.100 |
Why?
| | Pulmonary Medicine | 1 | 2013 | 85 | 0.100 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 293 | 0.100 |
Why?
| | History, 19th Century | 1 | 2012 | 60 | 0.100 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 286 | 0.100 |
Why?
| | Myocardial Infarction | 1 | 2020 | 1046 | 0.100 |
Why?
| | Self Efficacy | 1 | 2016 | 396 | 0.100 |
Why?
| | Health Policy | 1 | 2015 | 388 | 0.100 |
Why?
| | Nursing | 1 | 2012 | 37 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2012 | 96 | 0.090 |
Why?
| | Affective Symptoms | 1 | 2011 | 53 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1289 | 0.090 |
Why?
| | Irritable Mood | 1 | 2011 | 50 | 0.090 |
Why?
| | Intensive Care Units | 1 | 2017 | 827 | 0.090 |
Why?
| | History, 20th Century | 1 | 2012 | 325 | 0.090 |
Why?
| | Motor Skills | 1 | 2011 | 97 | 0.090 |
Why?
| | Italy | 2 | 2022 | 110 | 0.090 |
Why?
| | Education, Nursing | 1 | 2012 | 97 | 0.090 |
Why?
| | Forced Expiratory Volume | 3 | 2008 | 531 | 0.080 |
Why?
| | Evidence-Based Practice | 1 | 2012 | 229 | 0.080 |
Why?
| | Nurse Practitioners | 1 | 2011 | 138 | 0.080 |
Why?
| | Exercise Test | 3 | 2010 | 625 | 0.080 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 234 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 287 | 0.080 |
Why?
| | Tuberculosis | 1 | 2012 | 279 | 0.080 |
Why?
| | Respiratory Function Tests | 4 | 2008 | 600 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2016 | 986 | 0.070 |
Why?
| | Exercise | 1 | 2020 | 2057 | 0.070 |
Why?
| | Europe | 3 | 2015 | 414 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2011 | 496 | 0.070 |
Why?
| | Treatment Outcome | 6 | 2018 | 10811 | 0.070 |
Why?
| | Middle Aged | 7 | 2018 | 33479 | 0.060 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 548 | 0.060 |
Why?
| | Burnout, Professional | 1 | 2012 | 442 | 0.060 |
Why?
| | Video Recording | 1 | 2006 | 180 | 0.060 |
Why?
| | Metaphor | 1 | 2004 | 5 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7635 | 0.060 |
Why?
| | Psycholinguistics | 1 | 2004 | 20 | 0.050 |
Why?
| | Work of Breathing | 1 | 2003 | 3 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2006 | 275 | 0.050 |
Why?
| | Self Disclosure | 1 | 2003 | 63 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2003 | 2844 | 0.050 |
Why?
| | Male | 11 | 2022 | 67762 | 0.050 |
Why?
| | Chronic Disease | 3 | 2015 | 1793 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 131 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1329 | 0.050 |
Why?
| | Adult | 3 | 2018 | 37929 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3457 | 0.040 |
Why?
| | Theophylline | 1 | 2019 | 67 | 0.040 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 37 | 0.040 |
Why?
| | Cholinergic Antagonists | 1 | 2019 | 30 | 0.040 |
Why?
| | New Zealand | 1 | 2018 | 56 | 0.040 |
Why?
| | Time Factors | 2 | 2018 | 6828 | 0.030 |
Why?
| | Australia | 1 | 2018 | 315 | 0.030 |
Why?
| | Program Evaluation | 2 | 2013 | 898 | 0.030 |
Why?
| | Canada | 1 | 2018 | 418 | 0.030 |
Why?
| | Breathing Exercises | 2 | 2006 | 21 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2018 | 233 | 0.030 |
Why?
| | Polysomnography | 1 | 2017 | 185 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2022 | 806 | 0.030 |
Why?
| | Lung Transplantation | 1 | 2019 | 313 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 180 | 0.030 |
Why?
| | Positive-Pressure Respiration | 1 | 1976 | 80 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 591 | 0.030 |
Why?
| | Patient Selection | 1 | 2019 | 696 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.030 |
Why?
| | Health Care Costs | 1 | 2018 | 398 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1994 | 14 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Ambulatory Care | 1 | 1998 | 546 | 0.030 |
Why?
| | Rehabilitation | 1 | 2013 | 19 | 0.030 |
Why?
| | International Cooperation | 1 | 2013 | 198 | 0.030 |
Why?
| | Models, Organizational | 1 | 2013 | 151 | 0.020 |
Why?
| | North America | 1 | 2013 | 313 | 0.020 |
Why?
| | Prognosis | 2 | 2008 | 4030 | 0.020 |
Why?
| | Reference Values | 1 | 1994 | 816 | 0.020 |
Why?
| | Benchmarking | 1 | 2013 | 186 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 628 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2016 | 556 | 0.020 |
Why?
| | Pediatric Nursing | 1 | 2011 | 42 | 0.020 |
Why?
| | Oxygen | 1 | 1976 | 931 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2199 | 0.020 |
Why?
| | Proton Pump Inhibitors | 1 | 2011 | 109 | 0.020 |
Why?
| | Female | 6 | 2018 | 73304 | 0.020 |
Why?
| | Asthma | 1 | 2003 | 2295 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 31 | 0.020 |
Why?
| | Brazil | 1 | 2008 | 167 | 0.020 |
Why?
| | Reference Standards | 1 | 2008 | 186 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 86 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 786 | 0.020 |
Why?
| | China | 1 | 2008 | 217 | 0.020 |
Why?
| | Relaxation Therapy | 1 | 1987 | 17 | 0.020 |
Why?
| | Nursing Assessment | 1 | 1987 | 59 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 363 | 0.020 |
Why?
| | Respiratory Muscles | 1 | 2006 | 33 | 0.020 |
Why?
| | Social Support | 1 | 2010 | 618 | 0.020 |
Why?
| | Posture | 1 | 1987 | 185 | 0.020 |
Why?
| | Language | 1 | 2008 | 292 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 56 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2010 | 530 | 0.010 |
Why?
| | Survival Analysis | 1 | 2008 | 1325 | 0.010 |
Why?
| | Quality Assurance, Health Care | 1 | 2006 | 322 | 0.010 |
Why?
| | Program Development | 1 | 2006 | 364 | 0.010 |
Why?
| | Analgesics, Opioid | 1 | 2012 | 1000 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 485 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 2031 | 0.010 |
Why?
| | Respiratory Insufficiency | 1 | 2006 | 318 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 431 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2003 | 530 | 0.010 |
Why?
| | Heart | 1 | 2006 | 655 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 5131 | 0.010 |
Why?
| | Body Composition | 1 | 2006 | 684 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2003 | 1316 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 673 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3566 | 0.010 |
Why?
| | Anxiety | 1 | 2006 | 1035 | 0.010 |
Why?
| | Infant | 1 | 2011 | 9465 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5472 | 0.010 |
Why?
| | Depression | 1 | 2006 | 1397 | 0.010 |
Why?
| | Partial Pressure | 1 | 1976 | 30 | 0.010 |
Why?
| | Methods | 1 | 1976 | 65 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1724 | 0.010 |
Why?
| | Arteries | 1 | 1976 | 269 | 0.010 |
Why?
|
|
Lareau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|